Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ACN vs MRNA✓SelectedUSD · MRNAACN vs MRNA performance historyLatest closeAs of-4.93%11/18
Stock and ETF performance explorer

ACN vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+31.3%
MRNA return
+313.3%
Excess return
-282.1%
Maximum drawdown
-36.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.9%-4.8%-0.1%-4.8%
7D-10.3%-20.9%+10.6%-9.8%
30D-4.0%-13.3%+9.3%-3.8%
3M+32.6%+212.6%-180.0%+25.2%
All+31.3%+313.3%-282.1%+37.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling